India Medical Device Import Rules 2026: Proposed Expansion of Gateways
From Medical Device Global Market Access · 05:42
Show by Pure Global
On November 3, 2026, India's Ministry of Health proposed a draft amendment to expand the list of authorized import gateways for medical devices, drugs, and cosmetics under Rule 43A of the Drugs Rules, 1945. This episode details the twelve new proposed locations, including ten Inland Container Depots (ICDs) and the new Noida International Airport. We explore the government's goal of reducing logistics costs and transit times, analyze the impact on supply chain strategies for manufacturers, and outline practical steps that regulatory and logistics teams should take now to prepare for this significant change. Key Questions: - What specific changes are proposed to India's Rule 43A for medical device imports? - Which ten new Inland Container Depots are being considered as import gateways? - How will the inclusion of Noida International Airport affect supply chains in North India? - What is the government's primary goal with this proposed expansion? - How can this change reduce logistics costs and transit times for medical device importers? - What does this mean for manufacturers currently using congested ports like Mumbai or Chennai? - Is this a final rule, or is there an opportunity for industry feedback? - What practical steps should regulatory and supply chain teams take in response to this proposal? Sources: - https://www.thehindu.com/sci-tech/health/centre-proposes-10-new-import-gateways-for-drugs-medical-devices/article68828485.ece - https://maritimegateway.com/india-proposes-wider-import-gateway-network-for-medicines-and-medical-devices/ - https://www.business-standard.com/policy/centre-proposes-expanding-import-gateways-for-drugs-medical-devices-126110300424_1.html How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, helping them access global markets faster. Our experts develop efficient regulatory strategies, manage technical dossier submissions using advanced AI, and act as your local representative in over 30 markets, including India. We help you navigate complex requirements, from initial market research to post-market surveillance, ensuring your products remain compliant. To learn how Pure Global can streamline your market access, visit us at https://pureglobal.com, contact us at [email protected], or explore our free regulatory AI tools and database at https://pureglobal.ai.
More episodes of Medical Device Global Market Access
More episodes
- FDA IVD Emerging Pathogens Guidance: Validation for Section 564 Emergencies
- EU Harmonised Standards Update (November 2026): What MDR & IVDR Manufacturers Must Do Now
- China NMPA Medical Device GMP: Compliance for the November 1, 2026 Changes
- Mexico COFEPRIS Extends Medical Device Registration Renewals to 10 Years
- EU MDCG 2026-4 Rev. 1: Manufacturers Now Responsible for EUDAMED SSCP Uploads
- EU EUDAMED Device Registration Deadline: November 2026 Requirements for MDR and IVDR
- South Korea MFDS Proposes WHO Reliance for IVD Approvals
- UK MHRA Annual Fee Deadline: Urgent Action Required by November 6, 2026
- China NMPA GMP 2026: Navigating Post-Implementation Compliance and Inspections
- Australia TGA CDSS Exemption Changes: New 2026 Rules for SaMD
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.